We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why Is Globe Life (GL) Down 8.8% Since Last Earnings Report?
Read MoreHide Full Article
A month has gone by since the last earnings report for Globe Life (GL - Free Report) . Shares have lost about 8.8% in that time frame, underperforming the S&P 500.
But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Globe Life due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the latest earnings report in order to get a better handle on the important catalysts.
Globe Life Q3 Earnings Miss Estimates on Weak Underwriting Income
Globe Life Inc. reported third-quarter 2026 net operating income of $4.84 per share, which missed the Zacks Consensus Estimate of $4.87 by 0.6%. The bottom line, however, rose 0.6% year over year, driven by higher excess investment income and a lower diluted share count.
GL Benefits From Higher Premium Growth and Investment Income
Total premium revenues increased 6.5% year over year to $1.31 billion. Life insurance premiums rose 2.4% to $864.6 million, while health insurance premiums climbed 15.6% to $446.9 million, reflecting particularly strong growth at United American. Excluding realized investment gains/losses, revenue was about $1.61 billion, up 6%, driven by higher premium income and net investment income. The top line missed the Zacks Consensus Estimate by 0.8%.
Net investment income increased 3.5% year over year to $295.9 million. Excess investment income, a key profitability measure, increased 2.9% to $37.9 million, despite higher required interest on policy liabilities.
Globe Life Sees Pressure on Underwriting Margins
Insurance underwriting income decreased 4.2% year over year to $481.8 million. Life underwriting margin declined 4.9% to $458.2 million, while health underwriting margin increased 6.7% to $115.6 million. Administrative expenses increased 6% year over year to $95.2 million.
Total benefits and expenses increased 11.5% year over year to $1.15 billion, primarily due to higher policyholder benefits, amortization of deferred acquisition costs, commissions, premium taxes, acquisition costs and other operating expenses. These increases outpaced revenue growth and pressured profitability.
GL's Distribution Channels Deliver Mixed Results
Life insurance premium growth was led by the American Income division, where premiums increased 4% year over year to $470.4 million. Liberty National premiums rose 4% to $102 million, while Direct to Consumer premiums slipped 1% to $243.1 million. Overall life net sales decreased 1% to $149.1 million. Direct to Consumer sales declined 12%, while Liberty National sales increased 7%. American Income life net sales remained largely unchanged.
Health insurance continued to deliver stronger premium growth. United American health premiums rose 29% year over year to $219.3 million, while Family Heritage premiums increased 8% to $128.6 million. Direct to Consumer health premiums advanced 9%. Total health net sales increased 32% to $94.1 million, supported by a 95% increase at United American. However, United American recorded an underwriting loss of $6.4 million, compared with income of $16.1 million a year earlier, reflecting losses at Evry and excess Medicare Supplement claims.
Globe Life Strengthens Book Value and Returns Capital
Book value per share increased 22.8% year over year to $85.35. Excluding accumulated other comprehensive income (AOCI), book value per share increased 10.7% to $103.62. Net income return on equity was 19.7% for the first nine months of 2026, down from 21.9% in the year-ago period. Net operating income return on equity, excluding AOCI, was 15.9%, compared with 16.6% a year earlier. During the reported quarter, Globe Life repurchased 1.1 million shares for $185 million at an average price of $175.61 per share. The company now expects full-year repurchases of $725 million to $775 million, up from its previous projection of $670 million to $700 million.
Globe Life Revises 2026 Earnings Outlook
Globe Life adjusted its full-year 2026 net operating income guidance to a range of $15.35-$15.65 per share, citing adverse results at its United American General Agency division. For 2027, Globe Life projects net operating income of $16.10-$17.10 per share, representing a 7.1% increase at the midpoint.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed a downward trend in estimates review.
VGM Scores
At this time, Globe Life has a poor Growth Score of F, however its Momentum Score is doing a bit better with a D. However, the stock was allocated a grade of B on the value side, putting it in the second quintile for value investors.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Interestingly, Globe Life has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Image: Bigstock
Why Is Globe Life (GL) Down 8.8% Since Last Earnings Report?
A month has gone by since the last earnings report for Globe Life (GL - Free Report) . Shares have lost about 8.8% in that time frame, underperforming the S&P 500.
But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Globe Life due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the latest earnings report in order to get a better handle on the important catalysts.
Globe Life Q3 Earnings Miss Estimates on Weak Underwriting Income
Globe Life Inc. reported third-quarter 2026 net operating income of $4.84 per share, which missed the Zacks Consensus Estimate of $4.87 by 0.6%. The bottom line, however, rose 0.6% year over year, driven by higher excess investment income and a lower diluted share count.
GL Benefits From Higher Premium Growth and Investment Income
Total premium revenues increased 6.5% year over year to $1.31 billion. Life insurance premiums rose 2.4% to $864.6 million, while health insurance premiums climbed 15.6% to $446.9 million, reflecting particularly strong growth at United American. Excluding realized investment gains/losses, revenue was about $1.61 billion, up 6%, driven by higher premium income and net investment income. The top line missed the Zacks Consensus Estimate by 0.8%.
Net investment income increased 3.5% year over year to $295.9 million. Excess investment income, a key profitability measure, increased 2.9% to $37.9 million, despite higher required interest on policy liabilities.
Globe Life Sees Pressure on Underwriting Margins
Insurance underwriting income decreased 4.2% year over year to $481.8 million. Life underwriting margin declined 4.9% to $458.2 million, while health underwriting margin increased 6.7% to $115.6 million. Administrative expenses increased 6% year over year to $95.2 million.
Total benefits and expenses increased 11.5% year over year to $1.15 billion, primarily due to higher policyholder benefits, amortization of deferred acquisition costs, commissions, premium taxes, acquisition costs and other operating expenses. These increases outpaced revenue growth and pressured profitability.
GL's Distribution Channels Deliver Mixed Results
Life insurance premium growth was led by the American Income division, where premiums increased 4% year over year to $470.4 million. Liberty National premiums rose 4% to $102 million, while Direct to Consumer premiums slipped 1% to $243.1 million. Overall life net sales decreased 1% to $149.1 million. Direct to Consumer sales declined 12%, while Liberty National sales increased 7%. American Income life net sales remained largely unchanged.
Health insurance continued to deliver stronger premium growth. United American health premiums rose 29% year over year to $219.3 million, while Family Heritage premiums increased 8% to $128.6 million. Direct to Consumer health premiums advanced 9%. Total health net sales increased 32% to $94.1 million, supported by a 95% increase at United American. However, United American recorded an underwriting loss of $6.4 million, compared with income of $16.1 million a year earlier, reflecting losses at Evry and excess Medicare Supplement claims.
Globe Life Strengthens Book Value and Returns Capital
Book value per share increased 22.8% year over year to $85.35. Excluding accumulated other comprehensive income (AOCI), book value per share increased 10.7% to $103.62. Net income return on equity was 19.7% for the first nine months of 2026, down from 21.9% in the year-ago period. Net operating income return on equity, excluding AOCI, was 15.9%, compared with 16.6% a year earlier. During the reported quarter, Globe Life repurchased 1.1 million shares for $185 million at an average price of $175.61 per share. The company now expects full-year repurchases of $725 million to $775 million, up from its previous projection of $670 million to $700 million.
Globe Life Revises 2026 Earnings Outlook
Globe Life adjusted its full-year 2026 net operating income guidance to a range of $15.35-$15.65 per share, citing adverse results at its United American General Agency division. For 2027, Globe Life projects net operating income of $16.10-$17.10 per share, representing a 7.1% increase at the midpoint.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed a downward trend in estimates review.
VGM Scores
At this time, Globe Life has a poor Growth Score of F, however its Momentum Score is doing a bit better with a D. However, the stock was allocated a grade of B on the value side, putting it in the second quintile for value investors.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Interestingly, Globe Life has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.